Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrimidines as EGFR inhibitors and methods of treating disorders

Pyrimidines as EGFR inhibitors and methods of treating disorders

US Patent 10550112 · Granted Feb 4, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 2025
Potent and selective azaindole inhibitors of CDK8 and CDK192025
Bicyclic urea kinase inhibitors and uses thereof2025
Allosteric EGFR inhibitors and methods of use thereof2025
Allosteric EGFR inhibitors and methods of use thereof2025
Small molecule inhibitors of SRC tyrosine kinase2025
Degraders that target proteins via KEAP12025
Small-molecule focal adhesion kinase (FAK) inhibitors2025
Degradation of bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors w2025
Pyrimidines as EGFR-inhibitors and methods of treating disorders2025
Pyrimidines as EGFR-inhibitors and methods of treating disorders2025
Pyrimidines as EGFR-inhibitors and methods of treating disorders2025